Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?

Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?

Background/Aims Immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT) is affected by multiple variables during the transplantation. Methods We assessed the clinical factors contributing to immune function reconstitution at 100 days post-allogeneic HSCT in 114 pati...

Full description

Bibliographic Details
Main Authors:	Jin Park, Sung Hee Lim, Se Hyung Kim, Jina Yun, Chan Kyu Kim, Sang Cheol Lee, Jong Ho Won, Dae Sik Hong, Seong Kyu Park
Format:	Article
Language:	English
Published:	The Korean Association of Internal Medicine 2020-07-01
Series:	The Korean Journal of Internal Medicine
Subjects:	hematopoietic stem cell transplantation immunity treatment outcomes graft vs host disease
Online Access:	http://www.kjim.org/upload/pdf/kjim-2018-414.pdf

Similar Items

Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation
by: Severin eZinöcker, et al.
Published: (2012-11-01)

Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation
by: Riccardo Masetti, et al.
Published: (2021-01-01)

Brazilian workshop model to train investigators in chronic graft-versus-host disease clinical trials according to the 2005-2006 National Institutes of Health recommendations
by: Rita de Cássia Barbosa da Silva Tavares, et al.
Published: (2011-10-01)

Insufficient Antigen Presentation Due to Viral Immune Evasion Explains Lethal Cytomegalovirus Organ Disease After Allogeneic Hematopoietic Cell Transplantation
by: Rafaela Holtappels, et al.
Published: (2020-04-01)

Pityriasis rubra pilaris‐like graft‐vs‐host disease following allogeneic stem cell transplant in two patients
by: Jennifer Y. Wang, et al.
Published: (2019-12-01)

Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application
by: Koji Kato, et al.
Published: (2020-01-01)

Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation
by: Daniela Máira Cardozo, et al.

Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
by: Taeyun Kim, et al.
Published: (2020-03-01)

Predicting the clinical outcome of allogeneic hematopoietic stem cell transplantation: the long and winding road towards validated immune biomarkers
by: Alessandra eForcina, et al.
Published: (2013-03-01)

CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation
by: Antonella Mancusi, et al.
Published: (2019-12-01)

Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation
by: Eleni Gavriilaki, et al.
Published: (2021-02-01)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
by: Wei Du, et al.
Published: (2018-12-01)

Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation
by: Danilo Santana Alessio Franceschi, et al.
Published: (2011-01-01)

Can Graft vs. Leukemia Effect Be Uncoupled From Graft vs. Host Disease? An Examination of Proportions
by: Elizabeth Krieger, et al.
Published: (2020-04-01)

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
by: Raffaella Greco, et al.
Published: (2019-10-01)

Editorial: Cellular Therapies: Past, Present and Future
by: Ralf Dressel, et al.
Published: (2018-08-01)

Biomarkers for Allogeneic HCT Outcomes
by: Djamilatou Adom, et al.
Published: (2020-04-01)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
by: Abedin S, et al.
Published: (2020-11-01)

Helper Innate Lymphoid Cells in Allogenic Hematopoietic Stem Cell Transplantation and Graft Versus Host Disease
by: Linda Quatrini, et al.
Published: (2020-09-01)

Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation
by: Lixia Sheng, et al.
Published: (2020-07-01)

Immunomodulatory Effects of Histone Deacetylation Inhibitors in Graft-vs.-Host Disease After Allogeneic Stem Cell Transplantation
by: Xiaoxiao Xu, et al.
Published: (2021-02-01)

Bone Marrow Transplantation 1957-2019
by: Elizabeth Simpson, et al.
Published: (2019-06-01)

MiR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence
by: Sadaf eAtarod, et al.
Published: (2016-03-01)

Risk factors for short term thyroid dysfunction after hematopoietic stem cell transplantation in children
by: You Jin Jung, et al.
Published: (2013-07-01)

Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation
by: Ellen Fraint, et al.
Published: (2021-03-01)

Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center
by: Keyhanian S, et al.
Published: (2004-08-01)

Membranous nephropathy succeeding autologous hematopoietic stem cell transplant: a case report
by: Sanda Mrabet, et al.
Published: (2018-03-01)

Role of Pharmacogenetics in Hematopoietic Stem Cell Transplantation Outcome in Children
by: Raffaella Franca, et al.
Published: (2015-08-01)

A concise review on factors influencing the hematopoietic stem cell transplantation main outcomes
by: Mohammad Rafiee, et al.
Published: (2021-06-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Thoracic Air-Leakage Syndrome in Allogeneic Stem Cell Transplant Recipients as a Late Complication of Chronic Graft-versus-Host Disease: Case Reports
by: Jae Woo Park, et al.
Published: (2016-08-01)

Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT
by: Andrzej Frankiewicz, et al.
Published: (2020-07-01)

Importancia del estudio del quimerismo en el trasplante alogénico de médula ósea IMPORTANCE OF THE STUDY OF CHIMERISM IN THE ALLOGENEIC BONE MARROW TRANSPLANTATION
by: Ana M Amor Vigil, et al.
Published: (2003-12-01)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
by: Darel Martínez Bedoya, et al.
Published: (2021-03-01)

The influence of dental care associated with laser therapy on oral mucositis during allogeneic hematopoietic cell transplant: retrospective study
by: Fernanda de Paula Eduardo, et al.
Published: (2011-06-01)

Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation
by: MYu Drokov, et al.
Published: (2019-12-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.
by: hosein kamranzadeh fumani, et al.
Published: (2016-11-01)

The Role of Co-stimulatory/Co-inhibitory Signals in Graft-vs.-Host Disease
by: Sandeep Kumar, et al.
Published: (2018-12-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FANCONI ANEMIA; A SINGLE CENTRE EXPERIENCE
by: Tariq Azam Khattak, et al.
Published: (2021-02-01)

ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide
by: Laura Solán, et al.
Published: (2019-10-01)

Cannot write session to /tmp/vufind_sessions/sess_nvkuqnvtisclq6k45a2ndu847l